1.
One tube for all: 1-year outcomes after transition to Paul glaucoma implant at a tertiary centre.
Studsgaard Anne, Nielsen Stine Elkjær, Telinius Niklas
Acta OphthalmolJan 20255 citationsObservational Study
The Paul Glaucoma Implant effectively lowered IOP in refractory glaucoma patients over 12 months, significantly reducing medication burden, suggesting its utility in challenging cases.